查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1429971

2024 年結核病診斷全球市場報告

Tuberculosis Diagnostics Global Market Report 2024
出版日期: 按訂單生產 | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

結核病診斷的市場規模預計在未來幾年將顯著成長。預計到 2028 年將以 7.4% 的複合年成長率 (CAGR) 成長至 30.2 億美元。預計的成長將由政府的大力支持、FDA 對結核病診斷的核准增加、研究和開發的擴展以及抗藥性結核病的出現來推動。主要趨勢包括NGS平台的採用、產品創新、T細胞測試、人工智慧整合、行動裝置的使用以及政府和製造商之間的合作。

結核病病例的快速增加是結核病診斷需求不斷成長的主要驅動力，凸顯了市場的成長軌跡。結核病是一種傳染性呼吸道疾病，對健康構成嚴重威脅，並透過咳嗽或打噴嚏時釋放的空氣顆粒傳播。結核病診斷對於疾病的早期發現和診斷具有重要作用。美國疾病管制與預防中心 2022 年 3 月的每週報告就反映了這一趨勢的一個顯著例子，該報告顯示 2021 年美國結核病病例增加了 9.4%。報告病例總數達7,860例，而前一年為7,173例。因此，結核病發病率的上升已成為推動結核病診斷市場擴大的關鍵因素。

美國食品藥物管理局(FDA)核准結核病診斷的數量不斷增加，預計將進一步推動市場成長。一個說明性的例子是英國醫療診斷公司 PerkinElmer OxfordImmuntec 於 2023 年 3 月宣布推出另外兩款細胞分離儀器，即由 Allsheng Instruments 製造的 Auto-Pure 24 和 Auto-Pure 20B 平台。 FDA核准使用的此外，2022 年 10 月，PerkinElmer OxfordImmunotec 獲得 FDA核准，可以使用 T-Cell Select試劑組和 T-SPOT.TB 測試工作流程，由認可的實驗室用於體外診斷 (IVD)。自動化程度提高。 T-Cell Select 是一種週邊血單核細胞 (PBMC) 分離試劑，採用以微珠為基礎的細胞分離技術對 PBMC 進行正選，是一種受國際監管的試劑，旨在檢測潛伏性結核感染。T -SPOT.TB 測試，ELISPOT IGRA。 FDA 對新型結核病診斷方法的大量核准預計將加強並推動結核病診斷市場的成長。

目錄

第1章執行摘要

第2章 市場特點

第3章 市場趨勢與策略

第4章宏觀經濟情景

  • 高通膨對市場的影響
  • 烏克蘭與俄羅斯戰爭對市場的影響
  • COVID-19 對市場的影響

第5章世界市場規模與成長

  • 全球結核病診斷市場的驅動與限制因素
    • 市場驅動力
    • 市場限制
  • 2018-2023年全球結核病診斷市場規模表現與成長
  • 2023-2028、2033年全球結核病診斷市場規模及成長預測

第6章市場區隔

  • 全球結核病診斷市場，按測試類型細分、實際和預測，2018-2023、2023-2028、2033
  • 放射線檢查
  • 核酸檢測
  • 細胞激素檢測試驗
  • 抗藥性測試
  • 皮膚測試/曼圖測試（TST）
  • 血液/血清學測試
  • 塗片顯微鏡檢查
  • 基於細胞培養的測試
  • 其他測試類型
  • 全球結核病診斷市場，依疾病階段、績效及預測細分，2018-2023、2023-2028、2033
  • 潛伏性結核病
  • 活動性結核病
  • 全球結核診斷市場，依最終用戶細分，實際與預測，2018-2023、2023-2028、2033
  • 醫院和診斷實驗室
  • 醫生辦公室
  • 參考實驗室
  • 學術/研究設施

第 7 章 區域與國家分析

  • 全球結核病診斷市場，按地區、績效及預測，2018-2023、2023-2028、2033
  • 全球結核病診斷市場，依國家、績效及預測，2018-2023、2023-2028、2033

第8章亞太市場

第9章 中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章 義大利市場

第20章 西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章加拿大市場

第26章 南美洲市場

第27章 巴西市場

第28章 中東市場

第29章 非洲市場

第30章 競爭形勢及公司概況

  • 結核病診斷市場競爭形勢
  • 結核病診斷市場公司概況
    • Beckton, Dickinson and Company
    • F. Hoffmann-La Roche Ltd
    • Qiagen NV
    • BioMerieux SA
    • Danaher Corporation

第31章 其他大型創新公司

  • PerkinElmer
  • Thermo Fisher Scientific Inc.
  • Creative Diagnostics
  • Lionex GmbH
  • Biocartis
  • Bio-Techne India Private Limited
  • Bio-Rad laboratories India Pvt.Ltd
  • Zhejiang Di'an Diagnostics Technology Co., Ltd
  • ADICON Clinical Laboratories
  • Guangzhou Kingmed Diagnostics Center Co. Ltd.
  • Kindstar Global
  • OriGene Technologies
  • Siemens AG
  • Fresenius
  • Koninklijke Philips

第32章競爭基準化分析

第 33 章. 競爭對手儀表板

第34章 重大併購

第35章 未來前景與可能性分析

第36章附錄

簡介目錄
Product Code: r14942

Tuberculosis diagnostics encompass tools or tests characterized by high sensitivity and specificity in diagnosing TB and monitoring treatment effectiveness. They aim to identify acid-fast bacilli (AFB) in clinical samples and detect tuberculosis.

The tuberculosis diagnostics market comprises various types of tests such as radiographic testing, laboratory testing, nucleic acid testing, cytokine detection testing, drug resistance testing, skin test (TST)/Mantoux test, blood/serology tests, smear microscopy tests, cell culture-based tests, and other methods. Radiographic tests are utilized to identify chest abnormalities indicative of tuberculosis symptoms. These tests focus on diagnosing lesions that can manifest anywhere in the lungs, differing in cavitation, density, size, and shape. These diagnostic methods encompass nucleic acid testing (NAT), skin testing or Mantoux test (TST), blood testing or serology tests, smear microscopy, cultured-based tests, radiography tests, and other approaches. They serve various disease stages such as latent tuberculosis and active tuberculosis. End-users of tuberculosis diagnostics include hospitals, diagnostic laboratories, physician's office laboratories, reference laboratories, academic institutions, and research facilities.

The tuberculosis diagnostics market research report is one of a series of new reports from The Business Research Company that provides tuberculosis diagnostics market statistics, including tuberculosis diagnostics industry global market size, regional shares, competitors with a tuberculosis diagnostics market share, detailed tuberculosis diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the tuberculosis diagnostics industry. This tuberculosis diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The tuberculosis diagnostics market size has grown strongly in recent years. It will grow from $2.11 billion in 2023 to $2.27 billion in 2024 at a compound annual growth rate (CAGR) of 7.7%. The expansion observed during the historical period can be attributed to several factors. These include an increase in tuberculosis cases, higher healthcare spending, a rise in the number of healthcare facilities, and increased adoption of nucleic acid testing methods.

The tuberculosis diagnostics market size is expected to see strong growth in the next few years. It will grow to $3.02 billion in 2028 at a compound annual growth rate (CAGR) of 7.4%. Forecasted growth is driven by strong government support, increased FDA approvals for TB diagnostics, growing R&D, and the emergence of drug-resistant TB. Key trends include NGS platform adoption, product innovations, T cell tests, AI integration, portable device use, and government-manufacturer collaborations.

The surge in tuberculosis cases is a key driver behind the escalating demand for tuberculosis diagnostics, underscoring the market's growth trajectory. Tuberculosis, an infectious respiratory disease, poses a significant health threat and spreads through airborne particles released during coughing and sneezing. Tuberculosis diagnostics play a crucial role in the early detection and diagnosis of the disease. A notable example of this trend is evident in the Centers for Disease Control and Prevention's weekly report in March 2022, revealing a 9.4% increase in tuberculosis infections in the United States in 2021. The total reported cases reached 7,860, compared to 7,173 cases in the preceding year. Consequently, the rising incidence of tuberculosis is a key factor propelling the expansion of the tuberculosis diagnostics market.

The growing number of approvals from the US Food and Drug Administration (FDA) for tuberculosis diagnostics will further bolster market growth. An illustrative instance is the announcement made in March 2023 by PerkinElmer Oxford Immunotec, a UK-based medical diagnostics company, regarding the FDA approval for the use of two additional cell isolation instruments, Auto-Pure 24 and Auto-Pure 20B platforms, manufactured by Allsheng Instruments. Additionally, in October 2022, PerkinElmer Oxford Immunotec received FDA approval for the use of the T-Cell Select reagent kit, facilitating the automation of the T-SPOT.TB test workflow for in vitro diagnostic (IVD) use by certified laboratories. T-Cell Select, a peripheral blood mononuclear cell (PBMC) isolation reagent, employs positive selection of PBMCs with magnetic bead-based cell separation to streamline the preparation of cells for the T-SPOT.TB test-an internationally regulated ELISPOT IGRA designed for detecting latent tuberculosis infection. This influx of FDA approvals for novel tuberculosis diagnostics is anticipated to reinforce and drive the growth of the tuberculosis diagnostics market.

The prevailing trend shaping the tuberculosis diagnostics market is the adoption of technological innovations, with major market players actively integrating advanced technologies to maintain their market standing. Notably, companies are introducing sophisticated point-of-care (POC) diagnostic methods leveraging artificial intelligence (AI) technology. A case in point is the collaboration between Fujifilm, a Japan-based medical imaging device manufacturer, and Qure.ai, a US-based company specializing in AI-enabled medical imaging solutions. In August 2022, they jointly launched an advanced POC diagnostic method utilizing a battery-powered X-ray machine for tuberculosis diagnosis. The integration of artificial intelligence algorithms enhances testing programs, offering ultra-portability, high accuracy, and efficient solutions for point-of-care diagnostics.

A prominent trend in the tuberculosis diagnostics market is the emphasis on product innovations as companies strive to remain competitive and meet evolving consumer needs and preferences. Product innovation plays a pivotal role in generating enthusiasm, driving sales, and increasing brand awareness. Companies in the tuberculosis diagnostics sector are actively focusing on developing new product solutions to fortify their market positions. A noteworthy example is Redcliffe Labs, an India-based technology-empowered diagnostics service provider, which, in February 2023, introduced the BD MAX MDR TB (Tuberculosis) test. This diagnostic test, performed on the BD MAX molecular diagnostic system, enables clinicians to rapidly test for tuberculosis and multidrug resistance as a first-line test. Clinicians use the test to simultaneously detect bacteria causing TB and ascertain whether the bacteria exhibit mutations associated with resistance to two vital first-line drugs, Isoniazid (INH) and Rifampicin (RIF). This focus on product innovation is integral to strengthening companies' positions within the tuberculosis diagnostics market.

In March 2021, PerkinElmer, a US diagnostics and scientific research company, acquired Oxford Immunotec for $591 million. This strategic move enables PerkinElmer to broaden its portfolio of infectious disease testing solutions, particularly enhancing tuberculosis detection capabilities, catering to a global clientele. Oxford Immunotec, a UK-based company specializing in proprietary assays for immunology and infectious diseases, strengthens PerkinElmer's position in this critical sector.

Major companies operating in the tuberculosis diagnostics market report are Beckton, Dickinson and Company, F. Hoffmann-La Roche Ltd., Qiagen N.V, BioMerieux SA, Danaher Corporation, PerkinElmer, Thermo Fisher Scientific Inc., Creative Diagnostics, Lionex GmbH, Biocartis, Bio-Techne India Private Limited, Bio-Rad laboratories India Pvt.Ltd., Zhejiang Di'an Diagnostics Technology Co., Ltd., ADICON Clinical Laboratories, Guangzhou Kingmed Diagnostics Center Co. Ltd., Kindstar Global, OriGene Technologies, Siemens AG, Fresenius, Koninklijke Philips, Novartis, LumiraDx Limited, TestLine Clinical Diagnostics s.r.o., Hologic, Bayer AG, Cantel Medical Corporation, Meridian Bioscience, Johnson & Johnson, Abbott laboratories Immunodiagnostic Systems Holdings PLC, Mesa Biotech Inc, Pfizer, Agilent technologies Inc, AutoGenomics, AdvaCare Pharma, Akonni Biosystems Inc, Par Pharmaceutical, Epistem Limited, Gen-Probe, Sysmex South Africa (Pty) Ltd., Grifols S.A., Bio Certica, Biovac, BixBio

Asia-Pacific was the largest region in the tuberculosis diagnostics market in 2023. The regions covered in the tuberculosis diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the tuberculosis diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The tuberculosis diagnostics market includes revenues earned by entities by providing services related to diagnostic laboratory methods, detection of latent infection, detection of drug resistance, and diagnostic laboratory testings. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Tuberculosis Diagnostics Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on tuberculosis diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for tuberculosis diagnostics? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The tuberculosis diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Test Type: Radiographic Tests; Nucleic Acid Testing; Cytokine Detection Tests; Drug Resistance Tests; Skin Test / Mantoux Test (TST); Blood/Serology Test; Smear Microscopy Tests; Cell Culture-Based Tests; Other Test Types
  • 2) By Disease Stage: Latent Tuberculosis; Active Tuberculosis
  • 3) By End-User: Hospitals And Diagnostic Laboratories; Physician's Office Laboratories; Reference Laboratories; Academics And Research Facilities
  • Companies Mentioned: Beckton, Dickinson and Company; F. Hoffmann-La Roche Ltd; Qiagen N.V; BioMerieux SA; Danaher Corporation
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Tuberculosis Diagnostics Market Characteristics

3. Tuberculosis Diagnostics Market Trends And Strategies

4. Tuberculosis Diagnostics Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Tuberculosis Diagnostics Market Size and Growth

  • 5.1. Global Tuberculosis Diagnostics Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Tuberculosis Diagnostics Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Tuberculosis Diagnostics Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Tuberculosis Diagnostics Market Segmentation

  • 6.1. Global Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Radiographic Tests
  • Nucleic Acid Testing
  • Cytokine Detection Tests
  • Drug Resistance Tests
  • Skin Test / Mantoux Test (TST)
  • Blood/Serology Test
  • Smear Microscopy Tests
  • Cell Culture-Based Tests
  • Other Test Types
  • 6.2. Global Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Latent Tuberculosis
  • Active Tuberculosis
  • 6.3. Global Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals And Diagnostic Laboratories
  • Physician's Office Laboratories
  • Reference Laboratories
  • Academics And Research Facilities

7. Tuberculosis Diagnostics Market Regional And Country Analysis

  • 7.1. Global Tuberculosis Diagnostics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Tuberculosis Diagnostics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Tuberculosis Diagnostics Market

  • 8.1. Asia-Pacific Tuberculosis Diagnostics Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Tuberculosis Diagnostics Market

  • 9.1. China Tuberculosis Diagnostics Market Overview
  • 9.2. China Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Tuberculosis Diagnostics Market

  • 10.1. India Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Tuberculosis Diagnostics Market

  • 11.1. Japan Tuberculosis Diagnostics Market Overview
  • 11.2. Japan Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Tuberculosis Diagnostics Market

  • 12.1. Australia Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Tuberculosis Diagnostics Market

  • 13.1. Indonesia Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Tuberculosis Diagnostics Market

  • 14.1. South Korea Tuberculosis Diagnostics Market Overview
  • 14.2. South Korea Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Tuberculosis Diagnostics Market

  • 15.1. Western Europe Tuberculosis Diagnostics Market Overview
  • 15.2. Western Europe Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Tuberculosis Diagnostics Market

  • 16.1. UK Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Tuberculosis Diagnostics Market

  • 17.1. Germany Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Tuberculosis Diagnostics Market

  • 18.1. France Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Tuberculosis Diagnostics Market

  • 19.1. Italy Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Tuberculosis Diagnostics Market

  • 20.1. Spain Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Tuberculosis Diagnostics Market

  • 21.1. Eastern Europe Tuberculosis Diagnostics Market Overview
  • 21.2. Eastern Europe Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Tuberculosis Diagnostics Market

  • 22.1. Russia Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Tuberculosis Diagnostics Market

  • 23.1. North America Tuberculosis Diagnostics Market Overview
  • 23.2. North America Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Tuberculosis Diagnostics Market

  • 24.1. USA Tuberculosis Diagnostics Market Overview
  • 24.2. USA Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Tuberculosis Diagnostics Market

  • 25.1. Canada Tuberculosis Diagnostics Market Overview
  • 25.2. Canada Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Tuberculosis Diagnostics Market

  • 26.1. South America Tuberculosis Diagnostics Market Overview
  • 26.2. South America Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Tuberculosis Diagnostics Market

  • 27.1. Brazil Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Tuberculosis Diagnostics Market

  • 28.1. Middle East Tuberculosis Diagnostics Market Overview
  • 28.2. Middle East Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Tuberculosis Diagnostics Market

  • 29.1. Africa Tuberculosis Diagnostics Market Overview
  • 29.2. Africa Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Tuberculosis Diagnostics Market Competitive Landscape And Company Profiles

  • 30.1. Tuberculosis Diagnostics Market Competitive Landscape
  • 30.2. Tuberculosis Diagnostics Market Company Profiles
    • 30.2.1. Beckton, Dickinson and Company
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. F. Hoffmann-La Roche Ltd
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Qiagen N.V
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. BioMerieux SA
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Danaher Corporation
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Tuberculosis Diagnostics Market Other Major And Innovative Companies

  • 31.1. PerkinElmer
  • 31.2. Thermo Fisher Scientific Inc.
  • 31.3. Creative Diagnostics
  • 31.4. Lionex GmbH
  • 31.5. Biocartis
  • 31.6. Bio-Techne India Private Limited
  • 31.7. Bio-Rad laboratories India Pvt.Ltd
  • 31.8. Zhejiang Di'an Diagnostics Technology Co., Ltd
  • 31.9. ADICON Clinical Laboratories
  • 31.10. Guangzhou Kingmed Diagnostics Center Co. Ltd.
  • 31.11. Kindstar Global
  • 31.12. OriGene Technologies
  • 31.13. Siemens AG
  • 31.14. Fresenius
  • 31.15. Koninklijke Philips

32. Global Tuberculosis Diagnostics Market Competitive Benchmarking

33. Global Tuberculosis Diagnostics Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Tuberculosis Diagnostics Market

35. Tuberculosis Diagnostics Market Future Outlook and Potential Analysis

  • 35.1 Tuberculosis Diagnostics Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Tuberculosis Diagnostics Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Tuberculosis Diagnostics Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer